NASDAQ · INGN
Inogen Inc.
$6.31 +$0.16 (+2.60%) 1D Market openKey Metrics
$166.51M
Market cap
—
P/E · TTM
$351.50M
Revenue · TTM
−$24.90M
Net income
EPS · TTM
$-0.99
Dividend yield
—
Free cash flow
−$3.55M
Beta · 1Y
0.70
EBITDA · TTM
−$5.23M
Gross margin
44.3%
Snapshot
Market cap$166.51M
Enterprise value—
Shares outstanding27.1M
52-wk range$5.34 – $9.13
Avg volume · 20D249.7K
Net cash
—
Book value / share$7.27
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies
ExchangeNASDAQ
About Inogen Inc.
IPO dateFeb 14, 2014
Employees753
Inogen Inc is a medical technology business that focuses on respiratory health.
Wolf Grade COMING SOON
—
The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.
Valuation
P/E—
P/S0.47
P/FCF—
EV/EBITDA—
EV/Sales—
Graham №—
Profitability
Gross
44.3%
Operating
-7.3%
Net
-7.1%
FCF
-1.0%
ROE / ROIC
-14.0% · -34.2%
Financial Health
Current ratio3.10
Quick ratio2.70
Debt / equity—
Debt / EBITDA
—
Net cash
—
Working capital$129.22M
Cash Flow · TTM
Operating CF
−$1.11M
Capex
−$2.44M
Free cash flow
−$3.55M
Buybacks
—
Dividends paid
—
Shareholder yield
—
Piotroski F-Score
4 / 9
Middling fundamentals · 4 of 9 signals passing
Altman Z-Score
1.5
Distress zone (< 1.81) · elevated risk
Graham Number vs Price
—
Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings